US Stock MarketDetailed Quotes

Gain Therapeutics (GANX)

Watchlist

1.780
-0.020-1.11%

Close May 13 16:00 ET

1.810
+0.030+1.69%

Post 20:01 ET

75.92MMarket Cap-3.07P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Gain Therapeutics (GANX) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-23.71%-4.73M

2.16%-18.47M

-33.69%-4.62M

18.92%-4.93M

11.42%-5.1M

-6.55%-3.82M

-0.04%-18.87M

38.97%-3.45M

-53.18%-6.08M

-14.64%-5.76M

Net income from continuing operations

-23.81%-5.61M

1.23%-20.16M

-20.42%-4.54M

-17.81%-5.28M

28.66%-5.81M

-12.85%-4.53M

8.34%-20.41M

20.23%-3.77M

4.93%-4.49M

-5.92%-8.14M

Depreciation and amortization

3.11%21.3K

11.86%94.05K

32.54%28.24K

5.42%22.82K

8.43%22.33K

0.64%20.66K

0.59%84.07K

-9.67%21.31K

5.53%21.64K

1.75%20.59K

Other non cash items

110.29%230.46K

460.84%804.94K

-97.98%11.19K

124.59%10.86K

505.27%673.29K

154.76%109.59K

137.45%143.52K

508.25%553.98K

74.18%-44.18K

-462.31%-166.13K

Change In working capital

42.30%225.93K

6.84%-1.01M

15.94%-522.01K

92.95%-135.75K

-148.37%-507.53K

-61.91%158.78K

-344.30%-1.08M

54.98%-621.03K

-37,071.39%-1.93M

-23.37%1.05M

-Change in prepaid assets

66.91%-279.13K

79.01%-79.27K

-16.09%304.96K

2,304.04%866.94K

-1.07%-407.61K

-182.63%-843.56K

-952.08%-377.65K

1,782.88%363.45K

-121.74%-39.33K

-202.43%-403.3K

-Change in payables and accrued expense

-52.27%531.77K

-270.47%-468.61K

-1,252.26%-785.26K

48.80%-949.14K

-89.77%151.65K

58.35%1.11M

139.63%274.89K

94.35%-58.07K

-3,920.98%-1.85M

318.79%1.48M

-Change in other working capital

76.11%-26.71K

53.09%-458.64K

95.50%-41.71K

-64.90%-53.55K

-726.88%-251.58K

-1,057.25%-111.81K

-189.56%-977.63K

-149.48%-926.41K

76.81%-32.47K

-101.84%-30.43K

Cash from discontinued investing activities

Operating cash flow

-23.71%-4.73M

2.16%-18.47M

-33.69%-4.62M

18.92%-4.93M

11.42%-5.1M

-6.55%-3.82M

-0.04%-18.87M

38.97%-3.45M

-53.18%-6.08M

-14.64%-5.76M

Investing cash flow

Cash flow from continuing investing activities

-51.31%4.98M

-101.38%-43.45K

-100.00%-1

-34.25%2M

Net PPE purchase and sale

----

--0

----

-46.46%-22.49K

-4,873.68%-945

99.85%-1

-491.30%-21.55K

Net investment purchase and sale

----

--0

-51.16%5M

-101.35%-42.5K

--0

-33.62%2.02M

Cash from discontinued investing activities

Investing cash flow

----

--0

-51.31%4.98M

-101.38%-43.45K

-100.00%-1

-34.25%2M

Financing cash flow

Cash flow from continuing financing activities

-83.13%404.32K

118.63%28.45M

615.62%16.55M

769.67%7.03M

-75.42%2.47M

1,744.05%2.4M

2.93%13.01M

-75.81%2.31M

501.37%808.68K

356.75%10.04M

Net issuance payments of debt

-14.76%-25.53K

-6.19%-96.5K

-9.86%-25.03K

-8.13%-25K

-9.62%-24.24K

2.75%-22.24K

-2.03%-90.88K

-0.89%-22.78K

-2.15%-23.12K

0.61%-22.11K

Net common stock issuance

-82.32%427.78K

92.78%25.47M

462.98%13.15M

791.03%7.41M

-75.20%2.49M

--2.42M

3.79%13.21M

-75.63%2.34M

429.46%831.79K

352.55%10.04M

Proceeds from stock option exercised by employees

--2.06K

1,922.50%3.47M

342,706,800.00%3.43M

4,174,400.00%41.75K

--0

--171.51K

---1

--1

--13.58K

Net other financing activities

----

-40.81%-395.48K

--0

----

---280.87K

--0

Cash from discontinued financing activities

Financing cash flow

-83.13%404.32K

118.63%28.45M

615.62%16.55M

769.67%7.03M

-75.42%2.47M

1,744.05%2.4M

2.93%13.01M

-75.81%2.31M

501.37%808.68K

356.75%10.04M

Net cash flow

Beginning cash position

100.37%20.87M

-11.93%10.42M

-26.81%8.84M

-60.33%6.73M

-14.71%9.1M

-11.93%10.42M

61.10%11.83M

180.77%12.08M

167.14%16.97M

77.31%10.67M

Current changes in cash

-203.50%-4.32M

1,228.91%9.98M

1,106.77%11.93M

139.99%2.11M

-141.90%-2.63M

-99.60%-1.42M

-122.12%-884.24K

-116.83%-1.19M

-176.73%-5.27M

2,741.25%6.28M

Effect of exchange rate changes

-77.55%24.59K

189.92%474.03K

120.34%97.76K

-98.26%6.67K

1,881.94%260.07K

124.75%109.54K

-207.94%-527.17K

-199.45%-480.59K

364.77%382.81K

-88.21%13.12K

End cash Position

82.09%16.58M

100.37%20.87M

-26.81%8.84M

-60.33%6.73M

-14.71%9.1M

-11.93%10.42M

180.77%12.08M

167.14%16.97M

Free cash flow

-23.71%-4.73M

2.28%-18.47M

-33.65%-4.62M

18.92%-4.93M

11.75%-5.1M

-6.55%-3.82M

-0.08%-18.9M

38.95%-3.46M

-53.15%-6.08M

-14.98%-5.78M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-23.71%-4.73M	2.16%-18.47M	-33.69%-4.62M	18.92%-4.93M	11.42%-5.1M	-6.55%-3.82M	-0.04%-18.87M	38.97%-3.45M	-53.18%-6.08M	-14.64%-5.76M
Net income from continuing operations	-23.81%-5.61M	1.23%-20.16M	-20.42%-4.54M	-17.81%-5.28M	28.66%-5.81M	-12.85%-4.53M	8.34%-20.41M	20.23%-3.77M	4.93%-4.49M	-5.92%-8.14M
Depreciation and amortization	3.11%21.3K	11.86%94.05K	32.54%28.24K	5.42%22.82K	8.43%22.33K	0.64%20.66K	0.59%84.07K	-9.67%21.31K	5.53%21.64K	1.75%20.59K
Other non cash items	110.29%230.46K	460.84%804.94K	-97.98%11.19K	124.59%10.86K	505.27%673.29K	154.76%109.59K	137.45%143.52K	508.25%553.98K	74.18%-44.18K	-462.31%-166.13K
Change In working capital	42.30%225.93K	6.84%-1.01M	15.94%-522.01K	92.95%-135.75K	-148.37%-507.53K	-61.91%158.78K	-344.30%-1.08M	54.98%-621.03K	-37,071.39%-1.93M	-23.37%1.05M
-Change in prepaid assets	66.91%-279.13K	79.01%-79.27K	-16.09%304.96K	2,304.04%866.94K	-1.07%-407.61K	-182.63%-843.56K	-952.08%-377.65K	1,782.88%363.45K	-121.74%-39.33K	-202.43%-403.3K
-Change in payables and accrued expense	-52.27%531.77K	-270.47%-468.61K	-1,252.26%-785.26K	48.80%-949.14K	-89.77%151.65K	58.35%1.11M	139.63%274.89K	94.35%-58.07K	-3,920.98%-1.85M	318.79%1.48M
-Change in other working capital	76.11%-26.71K	53.09%-458.64K	95.50%-41.71K	-64.90%-53.55K	-726.88%-251.58K	-1,057.25%-111.81K	-189.56%-977.63K	-149.48%-926.41K	76.81%-32.47K	-101.84%-30.43K
Cash from discontinued investing activities
Operating cash flow	-23.71%-4.73M	2.16%-18.47M	-33.69%-4.62M	18.92%-4.93M	11.42%-5.1M	-6.55%-3.82M	-0.04%-18.87M	38.97%-3.45M	-53.18%-6.08M	-14.64%-5.76M
Investing cash flow
Cash flow from continuing investing activities		0	0	0	0	0	-51.31%4.98M	-101.38%-43.45K	-100.00%-1	-34.25%2M
Net PPE purchase and sale	----	--0	--0	--0	----	----	-46.46%-22.49K	-4,873.68%-945	99.85%-1	-491.30%-21.55K
Net investment purchase and sale	----	--0	--0	--0	--0	--0	-51.16%5M	-101.35%-42.5K	--0	-33.62%2.02M
Cash from discontinued investing activities
Investing cash flow	----	--0	--0	--0	--0	--0	-51.31%4.98M	-101.38%-43.45K	-100.00%-1	-34.25%2M
Financing cash flow
Cash flow from continuing financing activities	-83.13%404.32K	118.63%28.45M	615.62%16.55M	769.67%7.03M	-75.42%2.47M	1,744.05%2.4M	2.93%13.01M	-75.81%2.31M	501.37%808.68K	356.75%10.04M
Net issuance payments of debt	-14.76%-25.53K	-6.19%-96.5K	-9.86%-25.03K	-8.13%-25K	-9.62%-24.24K	2.75%-22.24K	-2.03%-90.88K	-0.89%-22.78K	-2.15%-23.12K	0.61%-22.11K
Net common stock issuance	-82.32%427.78K	92.78%25.47M	462.98%13.15M	791.03%7.41M	-75.20%2.49M	--2.42M	3.79%13.21M	-75.63%2.34M	429.46%831.79K	352.55%10.04M
Proceeds from stock option exercised by employees	--2.06K	1,922.50%3.47M	342,706,800.00%3.43M	4,174,400.00%41.75K	--0	--0	--171.51K	---1	--1	--13.58K
Net other financing activities	----	-40.81%-395.48K	--0	----	----	----	---280.87K	--0	--0	--0
Cash from discontinued financing activities
Financing cash flow	-83.13%404.32K	118.63%28.45M	615.62%16.55M	769.67%7.03M	-75.42%2.47M	1,744.05%2.4M	2.93%13.01M	-75.81%2.31M	501.37%808.68K	356.75%10.04M
Net cash flow
Beginning cash position	100.37%20.87M	-11.93%10.42M	-26.81%8.84M	-60.33%6.73M	-14.71%9.1M	-11.93%10.42M	61.10%11.83M	180.77%12.08M	167.14%16.97M	77.31%10.67M
Current changes in cash	-203.50%-4.32M	1,228.91%9.98M	1,106.77%11.93M	139.99%2.11M	-141.90%-2.63M	-99.60%-1.42M	-122.12%-884.24K	-116.83%-1.19M	-176.73%-5.27M	2,741.25%6.28M
Effect of exchange rate changes	-77.55%24.59K	189.92%474.03K	120.34%97.76K	-98.26%6.67K	1,881.94%260.07K	124.75%109.54K	-207.94%-527.17K	-199.45%-480.59K	364.77%382.81K	-88.21%13.12K
End cash Position	82.09%16.58M	100.37%20.87M	100.37%20.87M	-26.81%8.84M	-60.33%6.73M	-14.71%9.1M	-11.93%10.42M	-11.93%10.42M	180.77%12.08M	167.14%16.97M
Free cash flow	-23.71%-4.73M	2.28%-18.47M	-33.65%-4.62M	18.92%-4.93M	11.75%-5.1M	-6.55%-3.82M	-0.08%-18.9M	38.95%-3.46M	-53.15%-6.08M	-14.98%-5.78M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm